DGCI directs Serum Institute to suspend any new recruitment in phase 2, 3 COVID-19 vaccine clinical trials

On 9 September ANI first reported that DCGI issued a show-cause notice to Serum Institute for not pausing the ongoing clinical trial of the COVID-19 vaccine.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3ipy7ye
via IFTTT